Avai Bio (AVAI) Depreciation & Amortization (CF) (2019 - 2025)

Avai Bio has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $6517.0 for Q4 2025.

• Depreciation & Amortization (CF) for Q4 2025 came in at $6517.0, down 66.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $35319.0 (down 66.62% YoY), and the FY2025 annual result was $74320.0, down 3.42% from the prior year.
• Depreciation & Amortization (CF) came in at $6517.0 for Q4 2025 at Avai Bio, roughly flat from $6517.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $47267.0 in Q1 2024 to a low of -$3315.0 in Q4 2021.
• The 5-year median for Depreciation & Amortization (CF) is $11129.0 (2022), against an average of $12224.8.
• Across the five-year window, Depreciation & Amortization (CF) tumbled 123.06% in 2021 and surged 1135.74% in 2024, its largest moves.
• Avai Bio's Depreciation & Amortization (CF) stood at -$3315.0 in 2021, then soared by 215.38% to $3825.0 in 2022, then jumped by 168.44% to $10268.0 in 2023, then surged by 90.09% to $19518.0 in 2024, then plunged by 66.61% to $6517.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $6517.0 (Q4 2025), $6517.0 (Q3 2025), and $6518.0 (Q2 2025), per Business Quant data.